Article
Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation
1 Nov 1997
Abstract excerpt
The Leu-74 to Val (Leu74Val) mutation in human immunodeficiency virus type 1 reverse transcriptase (RT) develops as a consequence of didanosine (ddI) therapy and is associated with a decreased susceptibility to ddI. In this report, we provide evidence that the ddI-associated Leu74Val mutation confers a replication disadvantage to the virus. In a series of experiments, we have shown that (i) a cloned virus with an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
